Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
8141 - 8150 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2015
  • 2013
  • 2016
  • 2020
  • 2016
  • 2013
  • 2023
  • 2015
  • 2021
  • Disruption of the LRRK2‐FADD Interface Using Constrained Peptides
    2024
    Summary Details
    OPEN
    Title: Disruption of the LRRK2‐FADD Interface Using Constrained Peptides
    Author(s): Krista K. Alexander, Michalis Kentros, Leah G. Helton, Dimitris Tantis‐Tapeinos, Timothy J. LeClair, Fredejah Royer, Neil Grimsey, Alexia Polissidis, Eileen J. Kennedy, Hardy J. Rideout
    Journal Name: Peptide Science
    Publisher: Wiley
    Vol: 116
    Issue #: 6
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/pep2.24374
    Best OA location URL: https://doi.org/10.1002/pep2.24374
    Citation Count: 0
  • The link between mitochondrial complex I and brain-derived neurotrophic factor in SH-SY5Y cells – The potential of JNX1001 as a therapeutic agent
    2015
    Summary Details
    RESTRICTED
    Title: The link between mitochondrial complex I and brain-derived neurotrophic factor in SH-SY5Y cells – The potential of JNX1001 as a therapeutic agent
    Author(s): Helena K. Kim, Karina Martinez Mendonça, Patrick A. Howson, Jonathan M. Brotchie, Ana C. Andreazza
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Vol: 764
    Issue #:
    Start Page: 379
    End Page: 384
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2015.07.013
    Citation Count: 20
  • 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
    2013
    Summary Details
    RESTRICTED
    Title: 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
    Author(s): Elisabetta Tronci, Carlo Lisci, Roberto Stancampiano, Camino Fidalgo, Maria Collu, Paola Devoto, Manolo Carta
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Vol: 60
    Issue #:
    Start Page: 108
    End Page: 114
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.08.014
    Best OA location URL: https://doaj.org/article/65cb9c949d0049cbaa552f3b16529335
    Citation Count: 52
  • Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors
    2016
    Summary Details
    OPEN
    Title: Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors
    Author(s): Genta Ito, Kristina Katsemonova, Francesca Tonelli, Paweł Lis, Marco A. S. Baptista, Natalia Shpiro, Graham Duddy, Steve Wilson, Philip Wing‐Lok Ho, Shu‐Leong Ho, Alastair D. Reith, Dario R. Alessi
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Vol: 473
    Issue #: 17
    Start Page: 2671
    End Page: 2685
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20160557
    Best OA location URL: https://portlandpress.com/biochemj/article-pdf/473/17/2671/687564/bj4732671.pdf
    Citation Count: 170
  • Carepartner Communication on Parkinson Disease Psychosis (4116)
    2020
    Summary Details
    RESTRICTED
    Title: Carepartner Communication on Parkinson Disease Psychosis (4116)
    Author(s): Sneha Mantri, Emily Klawson, Steven Albert, Madeline Lepore, Catherine Kopil, Margaret Daeschler, Michelle Whitman, Eugenia Mamikonyan, Robyn Rapoport, Chelle Precht, Sarah Glancey, Steven Kahl, Connie Marras, Lana Chahine
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 94
    Issue #: 15_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4116
    Citation Count: 0
  • No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
    2016
    Summary Details
    OPEN
    Title: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
    Author(s): Claudia Cicognola, Davide Chiasserini, Paolo Eusebi, Ulf Andréasson, Hugo Vanderstichele, Henrik Zetterberg, Lucilla Parnetti, Kaj Blennow
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Vol: 11
    Issue #: 1
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-016-0130-3
    Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0130-3
    Citation Count: 21
  • Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats
    2013
    Summary Details
    OPEN
    Title: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats
    Author(s): Melissa M. Conti, Corinne Y. Ostock, David Lindenbach, Adam A. Goldenberg, Elias Kampton, Rich Dell'isola, Aaron Katzman, Christopher Bishop
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Vol: 77
    Issue #:
    Start Page: 1
    End Page: 8
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3865178
    Citation Count: 63
  • Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy
    2023
    Summary Details
    OPEN
    Title: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy
    Author(s): Thomas G. Beach, Lucia I. Sue, Sarah Scott, Anthony J. Intorcia, Jessica E. Walker, Richard Arce, Michael J. Glass, Claryssa I. Borja, Madison P. Cline, Spencer J. Hemmingsen, Sanaria H. Qiji, Analisa M. Stewart, Kayleigh N. Martinez, Addison Krupp, Rylee McHattie, Monica Mariner, Ileana Lorenzini, Angela Kuramoto, Kathy E. Long, Cécilia Tremblay, Richard J. Caselli, Bryan K. Woodruff, Steven Z. Rapscak, Christine M. Belden, Danielle Goldfarb, Parichita Choudhury, Erika Driver‐Dunckley, Shyamal H. Mehta, Marwan N. Sabbagh, Holly A. Shill, Alireza Atri, Charles H. Adler, Geidy E. Serrano
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Vol: 82
    Issue #: 6
    Start Page: 457
    End Page: 466
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlad026
    Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10209646/pdf/nlad026.pdf
    Citation Count: 13
  • Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
    2015
    Summary Details
    OPEN
    Title: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
    Author(s): Daniel Weintraub, Tanya Simuni, Chelsea Caspell‐Garcia, Christopher S. Coffey, Shirley Lasch, Andrew Siderowf, Dag Aarsland, Paolo Barone, David J. Burn, Lana M. Chahine, Jamie L. Eberling, Alberto J. Espay, Eric D. Foster, James B. Leverenz, Irene Litvan, Irene Hegeman Richard, Matthew D. Troyer, Keith A. Hawkins
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 30
    Issue #: 7
    Start Page: 919
    End Page: 927
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26170
    Best OA location URL: http://doi.org/10.1002/mds.26170
    Citation Count: 282
  • Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls
    2021
    Summary Details
    OPEN
    Title: Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls
    Author(s): Paniz Jasbi, Xiaojian Shi, Ping S. Chu, Natalie Elliott, Haley Hudson, Douglas C. Jones, Geidy E. Serrano, Brandon Chow, Thomas G. Beach, Li Liu, Garilyn Jentarra, Haiwei Gu
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Vol: 20
    Issue #: 9
    Start Page: 4303
    End Page: 4317
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.1c00290
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11060066
    Citation Count: 44
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.